In this issue:
Treatment persistence of biologics among Israeli patients with PsA
Concomitant fibromyalgia is common and negatively impacts disease activity indices and QoL
SELECT-PsA 2 demonstrates the efficacy of upadacitinib in patients with refractory disease
Adiposity increases the risk for developing PsA
Screening psoriasis patients for PsA
Biologic DMARD treatment persistence among German patients
Does ultrasound increase the accuracy of enthesitis assessment?
Real-world safety and effectiveness of secukinumab
Guselkumab elicits sustained efficacy at one-year regardless of TNF inhibitor exposure
Risk of methotrexate hepatotoxicity increased in PsA compared to rheumatoid arthritis
Please login below to download this issue (PDF)